Prostaglandins are arachidonic acid metabolites that may play a major role as mediators of cellular function. PGF 2␣ 1 has diverse physiological actions ranging from being a potent luteolytic agent (1, 2) to causing smooth muscle contraction in the uterus (3, 4), vasculature (5), and gastrointestinal (6) and respiratory tracts (7,8). PGF 2␣ induces DNA synthesis and cell proliferation in 3T3 fibroblasts (9, 10). Neuronal astrocytes respond to PGF 2␣ , which may mediate pain transmission (11). Recently, PGF 2␣ has also been shown to cause hypertrophy of cardiac myocytes and induction of myofibrillar genes, independent of muscle contraction. These observations suggest a role for the eicosanoid during development, in compensatory hypertrophy and/or in recovery of the heart from injury (12). Recently, PGF 2␣ analogs have been shown to reduce intraocular pressure (IOP), in patients with glaucoma (13,14). Although the precise mechanisms involved remain unclear, the effects of PGF 2␣ analogs on IOP may be attributed, at least in part, to their actions on the ciliary muscle. PGF 2␣ reduces IOP by increasing the uveoscleral outflow of aqueous humor (15, 16), possibly by reducing the resistance between the ciliary muscle bundles, via an effect on the extracellular matrix (17).A single PGF 2␣ receptor (FP) has been cloned from myometrial tissue (18 -22). Given that there is evidence consistent with splice variation of the FP (23), as has been described for other prostanoid receptors (24, 25), we wished to address the possibility that a distinct isoform might mediate the actions of PGF 2␣ in the ciliary muscle. Clarification of the nature of the human ciliary FP and development of an antibody that specifically recognized the receptor protein would facilitate investigation of the effects of PGF 2␣ and its analogs on IOP.PGF 2␣ is formed from arachidonic acid via metabolic transformation sequentially catalyzed by phospholipases, cyclooxygenases, and a specific PGF synthase (26). However, it is now appreciated that a series of PGF 2␣ isomers, the F 2 isoprostanes, may also be formed in vivo via a free radical-dependent pathway (27-29). It has been speculated that these F 2 isoprostanes may function as incidental ligands at eicosanoid receptors, and, possibly, activate related receptors of their own (30). To date, attention has focused particularly on 8-iso-PGF 2␣ . This compound is a potent vasoconstrictor. It is also a mitogen and may activate human platelets (31-33). Curiously, despite its F prostaglandin configuration, 8-iso-PGF 2␣ has been shown to activate thromboxane receptors (TPs), and its biological effects are blocked by TP antagonists (31-33).We now report the cloning of an FP receptor from the human ciliary body (hcb) cDNA library and its localization on the cell membrane. The gene product is identical to that cloned from